Skip to main content
OpenTrials
Completed

NCT Number: NCT04001751

Feasibility Study: Yoga Educational Project

As much as 45 to 60% of patients treated with hormonotherapy (HT) for breast cancer (BC) suffer from osteoarticular pain during treatment. Secondary effects have become a real issue because of their consequences on the patients' quality of life, but also on treatment efficacy and survival when they induce dose reduction or premature withdrawal of treatment.

Additional medicines (acupuncture, hypnosis, yoga) have become more and more popular these last years. 48 to 80% of patients with BC eventually choose them. A review comparing efficacy of various therapies to decrease osteoarticular pain concludes to a highest efficacy of anti-inflammatory treatments, paracetamol and yoga.

With this project, the investigators will assess the feasibility of a therapeutic yoga program with home practice for patients with breast cancer treated with hormonotherapy. The investigators will measure adhesion of the patients to perform yoga postures in an autonomous manner. Our study will also allow collection of data on the effect of such a program on quality of life, in view of setting-up an intervention study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Institut du Cancer de Montpellier

Montpellier, 34298, France

About this study

Numerous initiatives have started in France, often associative. It is essential to evaluate in a rigorous manner, these therapies before making them part of the patient's care pathway.

Yoga has shown a real benefit in terms of pain reduction in patients with BC treated with HT. These osteoarticular pains are the secondary effect on which a physical therapeutic care can have a real benefit.

It thus appears innovative to complete this care with a therapeutic education program (TEP) in postural yoga which will enable patients to practice yoga postures at home by themselves. Yoga allows a large adaptation to pains expressed by each patient. It will favor the development of the feeling of control that they have in particular on their pain. participants will so improve the self-efficacy, the quality of life, and will reduce their fatigue and their pain. The patients involved have already lived major body transformations because of the disease and treatments. Yoga will help them put their lives together again, both physically and psychologically, and reclaim their body.

Studies have shown the short-term effects of yoga practice on anxiety, stress, pain and quality of life. Few rare studies have suggested that patients could add yoga practice at home to the supervised sessions, but these studies lacked therapeutic patient education. To date, to our knowledge, no data on the effect of the realization of yoga postures at home on increase of the patients' self-competency feeling are available in France. Also, the long-term effects of such programs need to be assessed.

The Montpellier Cancer Institute (ICM) has set-up 8 years ago yoga sessions for women with breast cancer, together with an association located in Montpellier.

With this study, the investigators will assess the feasibility of an educational yoga program given by a trained physical therapist in patients with beast cancer treated with hormonotherapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Non metastatic breast cancer
  • Ongoing hormonotherapy, with no treatment modification in the 30 days before inclusion
  • Osteoarticular pain ≥ 4 (resting or moving) on the VAS (Visual Analogue Scale)
  • Previous treatment (surgery, chemotherapy or radiotherapy) ended at least 2 months before inclusion
  • Informed patient and signed informed consent received
  • Affiliation to a social security category

Exclusion criteria

  • Chronic rheumatologic pain with specific care needed
  • Yoga practice in the 3 months before inclusion
  • Contra-indication or clinical state not allowing physical practice

Treatment and study plan

educational yoga program

Behavioral

Daily 15-min yoga sessions at home with the "Le guide du yoga" and the audio-guide, during 12 weeks.

One 90-min yoga-therapeutic education session/week (during 6 weeks) given by a physical therapist trained to postural yoga.

Primary outcomes

  1. proportion of patient compliance to the educational yoga program

    Time frame: 12 weeks

    Compliance will be posittive if 70% of daily sessions at home and 4 sessions out of the 6 therapeutic educational (TEP) sessions delivered in the center by a physical therapist are realised

Secondary outcomes

  1. the patients' satisfaction towards the program

    Time frame: 12 weeks

    Satisfaction will be measured using the Likert scale (0 no satisfy to 10: strongly satisfy)

  2. the induced self-competency feeling

    Time frame: 12 weeks

    self-competency feeling induced will be assessed using the GSES (General Self Efficacy-Schwarzer) questionnaire (10 questions - scale 1- not at all true to 4-totally true)

  3. To assess quality of life by Quality of Life Questionnaire

    Time frame: 12 weeks

    Quality of life will be measured by EORTC QLQ-C30 (Quality of Life Questionnaire)

  4. To assess quality of life by Quality of Life Questionnaire specify for Breast Cancer

    Time frame: 12 weeks

    Quality of life will be measured by EORTC QLQ-Br23 (Quality of Life Questionnaire specify for Breast Cancer)

  5. To assess fatigue and stress

    Time frame: 12 weeks

    Fatigue and stress will be assessed using a Visual Analogous Scale (VAS) (0: no fatigue or no stress to 10 - maximum fatigue or stress)

  6. Anxiety and depression prevalence

    Time frame: 12 weeks

    Anxiety and depression will be assessed by HADS (Hospital Anxiety and Depression Scale) questionnaire (7 questions about Anxiety and 7 questions about Depression)

  7. Osteoarticular pain

    Time frame: 12 weeks

    osteoarticular pain will be assessed using a Visual Analogous scale (0: no pain to 10: maximum pain)

  8. Forward-flexion flexibility

    Time frame: 12 weeks

    Forward-flexion flexibility is defined by the distance between the fingertips and the floor. It will be measured with a ruler.

  9. Respiratory capacity

    Time frame: 12 weeks

    Respiratory capacity will be measured with a spirometer

  10. Compliance to hormonotherapy treatment

    Time frame: 12 weeks

    Taking hormonotherapy treatments will be reported in a log-book by the patients.

  11. Patient enrolment rate

    Time frame: at baseline

    The patient enrolment rate will be estimated (i.e. the proportion of patients giving their consent to participate in the study among eligible screened patients).

  12. Reasons of non-participation to the study.

    Time frame: at baseline

    The reason of non-participation to the study (difficulty of coming, not concerning by the project, not interesting by the project, fatigue, other) will be reported by the patient to the doctor.

Sponsors and collaborators

Lead sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Other

Registry information

Official study title

Feasibility Study of the "SKYPE" Educational Project in Patients With Breast Cancer Treated With Hormonotherapy

Acronym: SKYPE

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jun 28, 2019
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.